Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are more common than
previously thought and second only to colorectal cancers as the most prevalent …

Introduction: Neuroendocrine tumors are a heterogeneous group of malignancies,
characterised by production of hormones and vasoactive peptides. The incidence of …

Introduction: Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are unique and
complex neoplasms, exhibiting a wide spectrum of diverse clinical behaviors. The …

Treatment options for neuroendocrine tumors (NETs) and carcinomas (NECs) are
expanding. Early-phase studies have shown preliminary evidence of the antitumor activity of …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of
neoplasms arising from the diffuse neuroendocrine system. The incidence of GEP-NETs has …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare and heterogeneous
class of neoplasms. While surgical resection is the mainstay of treatment, non-surgical …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare, generally indolent
neoplasms that can arise throughout the gastrointestinal system. Some GEP-NETs, known …

Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of carcinomas
that remain difficult to treat with conventional cytotoxic regimens. The 2014 American Society …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare malignancies that
originate in the gastrointestinal system. GEP-NETs are typically indolent, but tumors known …

Patients with neuroendocrine tumours (NETs) are best managed in a specialist centre as
part of a multidisciplinary team comprising gastroenterologists, oncologists …